About us
The Cellular and Molecular Therapies (CMT) function within NHS Blood and Transplant is responsible for the routine provision of stem cells for transplantation across the country and for the development and manufacture of novel advanced cell therapies.
CMT also includes the Clinical Biotechnology Centre, which manufactures GMP-grade DNA plasmids and viral vectors.